Herbal fizz tablets aim to tame type 2 diabetes in small new study
NCT ID NCT06961019
First seen Feb 05, 2026 · Last updated Jun 13, 2026 · Updated 22 times
Summary
This early study tests whether herbal effervescent tablets can help control blood sugar in people with type 2 diabetes. It involves 14 adults aged 18-65 who either manage their diabetes with diet and supplements or take a low dose of metformin. The main goal is to see if the tablets safely lower HbA1c, fasting blood sugar, and after-meal blood sugar over the study period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NovoBliss Research Pvt Ltd
RECRUITINGAhmedabad, Gujarat, 382481, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.